Support & Resources

+1

DiR

DiR is a lipophilic, near-infrared fluorescent cyanine dye. The dye is useful for labeling cytoplasmic membranes and has been used for near-infrared in vivo imaging.

Product Attributes

CAS number

100068-60-8

Probe cellular localization

Membrane/cell surface, Membrane/vesicular

For live or fixed cells

For fixed cells, For live/intact cells

Fixation options

Permeabilize before staining, Fix after staining (formaldehyde), Fix before staining (formaldehyde)

Colors

Near-infrared

Excitation/Emission

748/780 nm

Learn more about

Technology

Size
Catalog #
price
Qty
5 x 1 mg
10 mg
Clear selection
ADD TO CART
(Please select quantity above )

Wishlist updated! View wishlist

Product Description

DiR (DiIC18(7); 1,1′-dioctadecyl-3,3,3′,3′-tetramethylindotricarbocyanine iodide) is a lipophilic, near-infrared fluorescent cyanine dye. The dye is useful for labeling cytoplasmic membranes and has been used for near-infrared in vivo imaging. The two long 18-carbon chains insert into the cell membrane, resulting in specific and stable cell staining with no or minimal dye transfer between cells. A stock solution of the dye can be made in ethanol. Cell staining can be effected using the dye at 1-10 uM concentration and 10-20 min incubation time.

Please also see our near-infrared CellBrite™ NIR Cytoplasmic Membrane Dyes, as well as CellBrite™ Cytoplasmic Membrane Stains available in a variety of colors.

  • λExEm (MeOH) = 748/780 nm
  • ε = 270,000
  • Dark blue-green oily solid soluble in ethanol, DMF or DMSO
  • Store at 4°C and protect from light
  • C63H101IN2
  • MW: 1013.4
  • [100068-60-8]

References

1. Biomaterials 34, 9171 (2013). http://dx.doi.org/10.1016/j.biomaterials.2013.08.039

2. J Control Release (2013) http://dx.doi.org/10.1016/j.jconrel.2013.10.002

3. Biomaterials (2013), http://dx.doi.org/10.1016/j.biomaterials.2013.09.094

4. Biomaterials (2013), http://dx.doi.org/10.1016/j.biomaterials.2013.09.089

5. International Journal of Nanomedicine 8, 2473–2485 (2013).

6. Bioconjugate Chemistry (2013) doi: 10.1021/bc400055h

7. International Journal of Pharmaceutics (2013), http://dx.doi.org/10.1016/j.ijpharm.2013.05.015

8. Pharm Res (2013) doi: 10.1007/s11095-013-1055-y

9. Biomaterials (2013), http://dx.doi.org/10.1016/j.biomaterials.2013.03.097

10. International Journal of Nanomedicine 8, 1573–1593 (2013)

11. International Journal of Nanomedicine 8, 1463–1476 (2013)

12. Biomaterials (2013), http://dx.doi.org/10.1016/j.biomaterials.2013.03.036

13. Biomaterials (2013), http://dx.doi.org/10.1016/j.biomaterials.2013.02.013

14. Biomaterials (2013), http://dx.doi.org/10.1016/j.biomaterials.2012.12.049

15. Biomaterials (2012), http://dx.doi.org/10.1016/j.biomaterials.2012.12.012

16. Biomaterials (2013), http://dx.doi.org/10.1016/j.biomaterials.2012.11.016

17. International Journal of Nanomedicine 7, 163–175 (2012)

18. J. Control. Release (2012) doi:10.1016/j.jconrel.2011.12.017

19. Pharm Res (2011) doi: 10.1007/s11095-011-0641-0

20. Biomaterials (2011) doi:10.1016/j.biomaterials.2011.10.035

21. International Journal of Pharmaceutics (2011) doi:10.1016/j.ijpharm.2011.09.008

22. Molecular Pharmaceutics (2011) doi: 10.1021/mp200100f

23. International Journal of Pharmaceutics (2011) doi:10.1016/j.ijpharm.2011.08.052

24. International Journal of Pharmaceutics (2011) doi:10.1016/j.ijpharm.2011.07.021

25. Molecular Pharmaceutics (2010) doi: 10.1021/mp100277h

26. Journal of Controlled Release (2013), http://dx.doi.org/10.1016/j.jconrel.2013.10.026

27. Biomaterials (2013), http://dx.doi.org/10.1016/j.biomaterials.2013.09.062

28. PLoS ONE (2013), doi:10.1371/journal.pone.0085003

29. Int J Pharmaceut (2013), http://dx.doi.org/10.1016/j.ijpharm.2013.12.016

30. Journal of Drug Targeting (2014), http://informahealthcare.com/doi/abs/10.3109/1061186X.2013.851683

31. ACS Nano (2014), doi: 10.1021/nn405155b

32. Molecular Pharmaceutics (2014), doi: 10.1021/mp400751g

33. Int J Pharmaceut (2014), http://dx.doi.org/10.1016/j.ijpharm.2014.03.012

34. Biomaterials (2014), http://dx.doi.org/10.1016/j.biomaterials.2014.03.012

35. Int J Pharmaceut (2014), http://dx.doi.org/10.1016/j.ijpharm.2014.04.008

36. Biomaterials (2014), http://dx.doi.org/10.1016/j.biomaterials.2014.03.036

37. Drug Delivery (2014), doi:10.3109/10717544.2014.903580

38. Biomaterials (2014), http://dx.doi.org/10.1016/j.biomaterials.2014.04.031

39. Pharm Res. (2014), doi: 10.1007/s11095-014-1400-9

40. Small (2014), doi: 10.1002/smll.201302786

41. Biomaterials (2014), http://dx.doi.org/10.1016/j.biomaterials.2014.04.117

42. Biomaterials (2014), http://dx.doi.org/10.1016/j.biomaterials.2014.06.022

43. Mol. Pharmaceutics (2014), dx.doi.org/10.1021/mp500113p

44. Vaccine (2014), http://dx.doi.org/10.1016/j.vaccine.2014.07.081

45. Journal of controlled release (2014), http://dx.doi.org/10.1016/j.jconrel.2014.09.029

46. Biomaterials (2014), http://dx.doi.org/10.1016/j.biomaterials.2014.09.008

47. International Journal of Nanomedicine 9, 5261–5271(2014).

48. Journal of pharmaceutical sciences (2014), doi: 10.1002/jps.24291

49. Biomaterials (2014), http://dx.doi.org/10.1016/j.biomaterials.2014.11.044

50. Int J Pharmaceut (2014), http://dx.doi.org/10.1016/j.ijpharm.2014.12.039

51. Acta Biomater (2015), http://dx.doi.org/10.1016/j.actbio.2015.01.010

52. Polym. Chem. (2015), doi: 10.1039/C4PY01422G

53. Biointerfaces (2015), http://dx.doi.org/10.1016/j.colsurfb.2015.02.041

54. ONCOLOGY LETTERS (2015), doi: 10.3892/ol.2015.3242

55. Acta Biomaterialia (2015), http://dx.doi.org/10.1016/j.actbio.2015.05.021

56. Drug Delivery (2015), http://informahealthcare.com/doi/abs/10.3109/10717544.2015.1040527

57. Journal of Drug Targeting (2015), doi:10.3109/1061186X.2015.1058800

58. Journal of drug targeting (2015), doi:10.3109/1061186X.2015.1064435

59. Nanomedicine (2015), doi:10.2217/nnm.15.106

60. Molecular Pharmaceutics (2015), doi: 10.1021/acs.molpharmaceut.5b00222

61. Bio-Medical Materials and Engineering 26 (2015), doi: 10.3233/BME-151384

62. ACS Appl. Mater. Interfaces (2015), doi: 10.1021/acsami.5b06043

63. International Journal of Pharmaceutics (2015), doi:10.1016/j.ijpharm.2015.12.013

64. RSC Advances (2015), doi: 10.1039/c5ra22233h

65. Applied Materials Interfaces (2015), doi: 10.1021/acsami.5b09934

66. Applied Materials & Interfaces (2016), doi: 10.1021/acsami.6b00036

67. PLoS ONE (2016), doi:10.1371/journal.pone.0149952

68. Applied materials and interfaces (2016), doi: 10.1021/acsami.6b00668

69. Biomaterials (2016), doi: 10.1016/j.biomaterials.2016.04.015

70. Nanoscale (2016), doi: 10.1039/C6NR01749E

71. Biomaterials (2016), doi: 10.1016/j.biomaterials.2016.05.037

72. Theranostics (2016), doi: 10.7150/thno.15164

73. Biomaterials (2016), http://dx.doi.org/10.1016/j.biomaterials.2016.06.048

74. Nanomedicine (2017), doi: 10.2217/nnm-2016-0408

75. J. Mater. Chem. B (2017), doi: 10.1039/C7TB01510K

76. Nanotechnology in Biomaterials (2017), doi: 10.1177/0885328217722740

77. Cancer Letters (2017), http://dx.doi.org/10.1016/j.canlet.2017.09.007

78. Colloids and Surfaces B: Biointerfaces (2017), https://doi.org/10.1016/j.colsurfb.2017.10.060

79. Photoacoustics (2017), https://doi.org/10.1016/j.pacs.2017.11.001

80. Applied Microbiology and Biotechnology (2018), https://doi.org/10.1007/s00253-018-8790-2

81. Artificial Cells, Nanomedicine, and Biotechnology (2018), doi: 10.1080/21691401.2018.1445093

82. Drug Delivery (2018), doi: 10.1080/10717544.2018.1446474

83. Neuropsychiatry (2018), doi: 10.4172/Neuropsychiatry.1000417

84. Biomaterials (2017), https://doi.org/10.1016/j.biomaterials.2017.09.013

 

You may also like…